Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2803 of 6351
-
New DNA test could spot leukemia resistance earlier
Diagnosis Not yet recruitingThe goal of this study is to asses the ability of digital PCR (ddPCR) to detect actionable mutations in adult CML patients with failure of TKI therapy. The main objective of the study is it aims to answer is to assess whether ddPCR is at least as effective as NGS in detecting act…
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Diagnosis
Last updated Jun 26, 2026 14:03 UTC
-
Can mealworm powder help fight child malnutrition? new trial aims to find out
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate whether a dietary supplement based on Tenebrio molitor (mealworm flour) can improve nutritional status and biomarkers of micronutrient deficiency in children aged 2-10 years. The main questions it aims to answer are: • Does regular…
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New hope for tough prostate cancer: experimental combo targets resistant tumors
Disease control Not yet recruitingThis open-label, single-arm study evaluates the safety and preliminary efficacy of LC-K76 combined with Tislelizumab and ADT in 10 patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) who progressed on prior therapies. Participants will receive oral LC-K76 and in…
Early phase 1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
AI learns to spot tricky bile duct cases before ERCP
Knowledge-focused Not yet recruitingThe main purpose of the study is to train a convolutional neural network (CNN) to predict difficult biliary canulation (DBC) following the European Society of Gastrointestinal Endoscopy Society (ESGE). Consecutive patients undergoing an endoscopic retrograde cholangiopancreatogra…
Sponsor: University of La Laguna • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
New ALS drug trial aims to tame inflammation
Disease control Not yet recruitingThis is a study of Kamlanoflast in patients with ALS. Kamlanoflast is orally administered over 24 weeks. Its effects on inflammatory and functional parameters will be studied. Information on safety and tolerability will be collected.
Phase 1/2 • Sponsor: Inflammasome Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Lung cancer drug anlotinib tested in Real-World review after treatment failure
Knowledge-focused Not yet recruitingPrevious studies on bevacizumab in colorectal and ovarian cancers have demonstrated that continued anti-angiogenic therapy after disease progression can still provide clinical benefits. As a typical multi-targeted anti-angiogenic tyrosine kinase inhibitor, anlotinib hydrochloride…
Sponsor: Henan Cancer Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Talking away the fear: CBT may boost hip replacement recovery
Symptom relief Recruiting nowThe goal of this clinical trial study is to evaluate the effectiveness of cognitive behavioral therapy in reducing kinesiophobia and improving Clinical outcomes in postoperative patients following total hip arthroplasty The main question it aims to answer is: Does the addition o…
Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New breathing technique could help obese heart surgery patients avoid ICU complications
Disease control Not yet recruitingMorbidly obese patients undergoing open heart surgery are at increased risk of breathing problems after removal of the breathing tube due to reduced lung function and chest wall restriction following surgery. These complications may result in poor oxygenation, respiratory failure…
Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Choice overload? HIV patients pick their own care path in new study
Disease control Not yet recruitingDisengagement from HIV care is very common in the first year after starting or restarting antiretroviral therapy (ART). There is increasing recognition of people cycling in and out of HIV care over time people newly starting and restarting treatment after an interruption are at h…
Sponsor: University of Cape Town • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Mindfulness may ease 'Scanxiety' for parents of kids with cancer
Symptom relief Recruiting now"Scanxiety" is a term coined to describe anxiety related to imaging during cancer treatment and has not been robustly studied in pediatric oncology caregivers. Mindfulness-based Stress Reduction (MBSR) is a meditation-based program that offers a non-pharmacologic approach to mana…
Sponsor: Kimberley Roche • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Nerve zapping eases migraine pain in new study
Symptom relief OngoingBackground: Central sensitization and cutaneous allodynia are key mechanisms implicated in migraine chronification and disability. Pulsed radiofrequency (PRF) of the greater occipital nerve (GON) has emerged as a neuromodulatory intervention for refractory headache disorders; how…
Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New combo therapy could boost fluid removal in heart failure
Symptom relief Recruiting nowThe aim of this study is to compare the efficacy and safety of empagliflozin, acetazolamide, and metolazone as add-on therapies to loop diuretics in patients with acute decompensated heart failure.
Phase 2 • Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New drug aims to tackle two conditions at once: heart disease and erectile dysfunction
Disease control Not yet recruitingThis is a randomized, double-blind, placebo-controlled phase IIa clinical trial to evaluate the efficacy and safety of YN001 in patients with atherosclerotic cardiovascular and cerebrovascular diseases and erectile dysfunction
Phase 2 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
App-Based therapy aims to curb Self-Harm in teens
Symptom relief Not yet recruitingTo evaluate if evidence-based digital cognitive behaviour therapy for adolescents is an efficacious treatment when delivered as an adjunctive treatment to treatment as usual, compared to a control group consisting of treatment as usual.
Sponsor: Peking University Sixth Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
New hope for goiter sufferers: blocking blood flow to nodules may ease breathing trouble
Symptom relief Recruiting nowVery few studies have investigated TAE as a treatment for goiter with compressive symptoms. What is the efficacy and safety of TAE for the treatment of compressive goiters in a population ineligible for or refusing standard therapy? This is a prospective interventional cohort stu…
Sponsor: Université de Sherbrooke • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Virtual reality workouts tested for rare lung condition
Symptom relief By invitation onlyThe goal of this research is to investigate the effectiveness of exercise administered via immersive virtual reality in patients with pulmonary hypertension, thereby contributing to the existing literature on this subject. The main question is whether exercises delivered via imme…
Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Proactive Follow-Up program aims to keep thyroid patients on track
Disease control Recruiting nowPatients after thyroid cancer surgery face multiple challenges, including recurrence monitoring, medication adjustment, complication management (e.g., hypoparathyroidism, vocal cord dysfunction), and long-term psychosocial adaptation. Studies confirm that standardized long-term f…
Sponsor: Yu Feng • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New risk tool could predict cancer return after liver surgery
Knowledge-focused Not yet recruitingThe goal of this observational study is to develop an integrated clinical-molecular risk stratification to identifypatients who are at high risk of recurrence and who would benefit from adjuvant chemotherapy in patients with recectable colorectal liver metastases. The main questi…
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
New lens option may reduce need for glasses after cataract surgery in glaucoma patients
Symptom relief Not yet recruitingCataract is the leading cause of reversible vision loss, while glaucoma remains the primary cause of irreversible blindness, often impairing contrast sensitivity (CS), glare tolerance, and dark adaptation. These visual challenges are particularly relevant when selecting intraocul…
Sponsor: OMIQ Research • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Can a phone app help teens with chronic pain get better faster?
Symptom relief By invitation onlyThe goal of this clinical trial is to learn if the addition of physical exercise and mindfulness training, delivered by a mobile application, to multimodal pain rehabilitation could lead to a mor effective rehabilitation process and improved outcomes. The main questions it aims t…
Sponsor: Linkoeping University • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC